Quantitative Proteomics Reveals Novel Immunomodulatory Pathways of Resistance to PARP Therapy - Biognosys

Quantitative Proteomics Reveals Novel Immunomodulatory Pathways of Resistance to PARP Therapy

E-Poster presented at AACR 2020

Presenter: Kristina Beeler, PhD
A collaboration with: Cancer Research UK Cambridge Institute

Back to Resources overview

Helpdesk

Access our knowledge base with relevant resources and guiding information.

Contact

    Close banner

    Spectronaut® 16

    The Deepest Proteome
    Coverage Available

    New: Spectronaut® 16

    The Deepest Proteome Coverage Available

    learn more